Life Sciences Academy by Osborne Clarke

Helping you to navigate legal and compliance challenges in the Life Sciences and Healthcare industry

Get ahead

Stay one step ahead regarding regulatory changes in the Life Sciences and Healthcare sector.

Our renowned experts are putting their advanced scientific qualifications and industry experience to good use. They will not only bring you up to speed on the most important legal and compliance topics in your sector, but also provide you with hands-on examples, as well as practical solutions, to help solve your most pressing legal challenges.

Our special focus? 

Regulations relevant to healthcare companies in Europe and from the US, looking to establish and expand their footprint in the EU. To benefit from our know-how in the areas of digital business, information technology, healthcare and consumer goods, sign up to our webinar series now!

It was an excellent webinar. The content was incredibly relevant and useful for my role. It is very rare that webinars actually cover the points that you need clarified and yours did so consistently throughout the hour. An excellent use of my time and I w Sam Cookman - Head of Legal at Elekta Limited
… a truly wonderful format and a very interesting workshop. Osborne Clarke demonstrates issues their clients in the life sciences sector face in practice. The information provided is not so deep that one gets lost, but rather well-balanced.

2026 webinars

Unlocking Health Data for Cross-Border AI Innovation

Navigating Privacy Compliance in the EU and UK

Our case study explores a health care / life sciences organisation seeking to leverage existing health data to develop an AI technology. The health data was collected years ago under broad consent for "future research." Now it needs to flow across borders and be further processed for AI development. Join three of Osborne Clarke's international health data experts as they dissect this real-world scenario and show you how to navigate the legal maze of cross-border health data innovation under EU and UK privacy law.

What you'll learn

  • Broad consent and legal basis: When is consent from clinical trials sufficient for commercial AI development, and how do national approaches differ across jurisdictions?
  • Pseudonymisation vs anonymisation: What is the impact of recent CJEU rulings on data privacy for these types of cross-border health research projects? Can this decision reduce the compliance burden in the context of international AI research projects?
  • Emerging regulation: Do the EHDS or the Digital Omnibus provide permission grounds to re-use health data for AI innovation projects?
  • Cross-border data transfers and multi-party responsibilities: How can you overcome the practical challenges of moving health data internationally between several stakeholders?

Webinar recorded 10th March 2026

View webinar
Navigating US Biosecurity Rules

Biosecure Act and Its Impact on Global Biotech/Pharma

US biosecurity policy is rapidly evolving. The proposed Biosecure Act and related regulations are poised to reshape how biotech and pharma companies source, partner, and invest across borders. This webinar breaks down what’s changing, who is affected, and what EU/UK companies with US touchpoints should be doing now. We cover:

  • Expected timelines, scope, and obligations under the Biosecure Act
  • How other related regulations impact supply chains, research collaborations (including university/CRO arrangements), and capital flows
  • Practical steps to prepare—counterparty screening, contractual protections, JV/transaction structuring, and governance
  • Q&A session to help you translate policy awareness into concrete action.

Webinar recorded 12th February 2026

View webinar

Past webinars | 2025

M&A: The cross-border post-deal integration playbook

This practical webinar sets out a cross-border playbook for post-deal integration in life sciences, focusing on immediate post‑completion priorities and the early integration phase. Our panel of corporate, tax and regulatory specialists highlights common pitfalls and UK/EU nuances, sharing clear, actionable steps to maintain momentum and protect deal value.

Webinar recorded 23rd October 2025

View webinar
Freedom of research and trade secrets in a life sciences industry

How can employers in the Life Sciences and healthcare industry safeguard trade secrets without overstepping contractual freedom?

Join our webinar where we explore the delicate balance between regulating trade secrets after employment termination and preventing unfair competition, as well as presenting the focus topic of non-disclosure agreements. We also examine the remedies available under the Trade Secrets Directive for injunction and damages caused by former employees infringing on trade secret rights.

Webinar recorded 23 September 2025

View webinar
Unravelling the EHDS - what does it mean for health and life science companies?

Are you ready to navigate the complexities of the new European Health Data Space (EHDS) regulation? Join our webinar for an exclusive one-hour presentation where our experts explore the implications of this ground breaking new regulation that has a major impact on health and life sciences companies. Our team of experts guide you through the key aspects of the EHDS, offering practical insights and answering pressing questions for businesses.

Webinar recorded 17th June 2025

View webinar
Navigating the EU pharmaceutical reform: Key changes and strategic implications

Gain valuable insights and practical knowledge on the latest legislative changes in the EU pharmaceutical sector, including regulatory updates, data exclusivity, and supplementary protection certificates. This webinar equips attendees with the tools to adapt to the new regulatory environment and optimise their IP strategies.

Webinar recorded 20th May 2025
View webinar
New Trump Administration and Impact on Life Sciences and Healthcare

With multiple biotech and pharma hubs and world class research institutions, the United States is by some distance the world leader in life sciences R&D. For a large number of our clients, the US is also a core market for their products. Keeping abreast of regulatory and practical developments around doing business in the US is essential to maintaining commercial success.

Join us for an insightful webinar where our experts interview Michael P. Strazella, Senior Principal, Co-Head of Government Relations and Health Industry at Buchanan. Michael shares his expertise on the latest policy developments under the new Trump Administration and their implications for the life sciences and healthcare sectors.

Webinar recorded 30th April 2025

View webinar
Unlocking value: Mastering commercial terms in pharma and biotech license agreements

This webinar delves into the intricacies of commercial terms in pharma and biotech license agreements to maximise benefits. Our experts provide valuable tips on structuring these agreements to maximise benefits, with a focus on perspectives from both the UK and Germany. Key topics include royalty stacking, combination products, sublicense fees, and the net sales definition. Enhance your understanding and unlock the full potential of your licensing deals.

Webinar recorded 11 March 2025.

View webinar
Data Privacy and Governance for use of AI in Life Sciences and Healthcare

This webinar explores the delicate balance (or lack thereof) between regulation and innovation. Gain practical insights from experts in the UK and EU (Germany, Belgium, and France) on privacy law requirements, potential solutions through anonymisation or synthetic health data, opportunities for AI via the European Health Data Space (EHDS), and the ethical dimensions of AI in healthcare.

Webinar recorded 11th February 2025.

View webinar

Past webinars | 2024

Unveiling AI in Pharma & MedTech

From AI Protection to AI Innovation through case studies in the Pharma & MedTech Industries

We delve into the fascinating world of AI in pharma and medtech, exploring among other things, how AI tools and AI-developed results are protectable under relevant IP laws, and whether AI may be legally recognised as an ‘inventor’ or ‘creator’ from an IP law perspective. We also examine challenges surrounding the protection of training data and trade secrets and provide insights on contract compliance and contractual protection strategies.

Webinar recorded 10th December 2024

View webinar
Key lessons for Life Sciences from the first 18 months of the UPC

Our life sciences patent litigators build on their experience with the UPC and introduce the audience to the latest and most relevant case law for life sciences companies. We present practical steps to help businesses prepare to successfully enforce and defend their rights before the UPC.

Webinar recorded 19 November 2024

View webinar
Navigating Regulatory and IP Challenges in European M&A

We approach this webinar from the structure of a typical acquisition process of target companies active in the Life Sciences sector. We discuss regulatory and IP items that we often encounter in Europe and explain how they can impact the overall acquisition process and timing.

Webinar recorded 29th October 2024

View webinar
How foreign direct investment controls impact M&A transactions and investments in the LSH sector

An exclusive webinar which dives deep into the intricate world of foreign direct investment (FDI) regulation, unravelling the complexities of FDI controls and their significant influence on M&A transactions and investments within the life sciences and healthcare sector.

Webinar recorded 10th September 2024

View webinar
Essential Safeguards: Preparing for Your Licensor’s Bankruptcy in License Agreements

Our top legal experts from Germany, the UK, and China provide valuable insights and practical strategies to secure your in-licensed assets in license agreements.

Webinar recorded 16 July 2024

View webinar
Our latest insights
View all insights

Connect with one of our experts